Category: CovidienSyndicate content

Medtronic and Covidien reveal their integration teams

August 19, 2014 by Arezu Sarvestani

Medtech titans Medtronic and Covidien name more than 45 people to coordinate the finer points of their merger.

Medtronic and Covidien reveal their integration dream-team

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

COV shareholder sues to block pending MDT merger | Medtech legal news for the week of August 18, 2014

August 18, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Another Covidien shareholder sues to block Medtronic merger; Ex-Integra sales rep, manager cop to $800k hospital fraud scheme; Diabetes: Medtronic, Johnson & Johnson settle patent spat; Stryker settles hip implant suit against J&J's DePuy; Appeals court reverses Medtronic's win in Lenox bone mill spat

Another Covidien shareholder sues to block Medtronic merger

August 12, 2014 by Brad Perriello

Amid political noise, Ishrak seeks to reassure employees on Medtronic-Covidien deal

August 15, 2014 by Brad Perriello

Medtronic CEO Omar Ishrak seeks to reassure employees amid the political fallout over the tax inversion aspects of its $43 billion deal to acquire Covidien.

Ishrak seeks to reassure employees on Medtronic-Covidien deal

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Will Medtronic follow Walgreen and abandon inversion in Covidien deal?

August 15, 2014 by Brad Perriello

Bearish options trades on Covidien are driven by speculation that Medtronic will follow Walgreen in abandoning plans for a so-called tax inversion deal, Bloomberg reports.

Will Medtronic follow Walgreen and abandon inversion in Covidien deal?

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic founder Bakken backs Covidien buy

August 15, 2014 by Brad Perriello

Earl Bakken, the founder of Medtronic, tells employees he's behind the company's $43 billion acquisition of Covidien and its potential to save a life every second.

Medtronic founder Bakken backs Covidien buy

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FTC wants more data on MDT-COV deal | Medtech Wall Street news for the week of August 11, 2014

August 14, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; Greatbatch acquires Uruguay's CCC Medical Devices; T2 Biosystems IPO raises $57M for MRI-based diagnostics; Strong Q4, $750M buyback give CareFusion a boost; Baxano: Strong Q2, new patents can't appease Wall Street

FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried

August 7, 2014 by Arezu Sarvestani

Analyst report: Dems can't stop Medtronic-Covidien merger

Allergan calls out Valeant on latest earnings report : The week in medtech M&A

August 13, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Valeant's hostile takeover hopes fade as Allergan war continues; Medtronic hires ex-Senators to lobby for Covidien deal; FTC wants more data on Medtronic-Covidien deal, but analysts aren't worried; St. Jude closes $200M NeuroTherm buy; Medtronic-Covidien merger means tax hit for all stockholders, including execs

Report: Valeant's hostile takeover hopes fade as Allergan war continues

August 6, 2014 by Arezu Sarvestani

Allergan attacks activist investor's latest earnings report
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp